• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 AXIUM; DEVICE, NEUROVASCULAR EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 AXIUM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Model Number UNK-NV-AXIUM
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cyst(s) (1800); Headache (1880); Muscle Weakness (1967); Paresis (1998); Swelling/ Edema (4577)
Event Date 12/26/2012
Event Type  Injury  
Manufacturer Narrative
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Grandhi, r., miller, r.A., zwagerman, n.T., lunsford, l.D., <(>&<)> horowitz, m.(2014).Perianeursymal cyst development after endovascular treatment of a ruptured giant aneurysm.Journal of neuroimaging¿: official journal of the american society of neuroimaging, 24(5), 515¿517.Https://doi.Org/10.1111/jon.12018 medtronic review of the literature article found that a 51 year-old male patient underwent a stent + coiling embolization procedure in january 2009 to treat a ruptured 27 mm right internal carotid artery bifurcation aneurysm.Axium coils were implanted in the procedure as well as a non-medtronic stent.The patient underwent periodic post-operative angiograms to screen for aneurysm regrowth.Over 3 years, the patient had four additional coil embolizations.In march 2012, he presented with progressively worsening headaches.Examination revealed mild left hemiparesis with 4/5 strength in the patient's left upper extremity (lue) and 4+/5 strength in left lower extremity (lle).The patient had normal strength on the right side.A head ct revealed the presence of a 4cm x 5cm low attenuation cystic lesion in the right basal ganglia which had not been observed 6 months prior.The patient underwent an awake, steriotactic cyst aspiration procedure to relieve symptoms and mass effect related to the cyst.The cytologic analysis of the aspirate revealed no cells, but a protein content of 5 ,000 mg/dl.The patient was discharged home a few days after cyst drainage.The only neurologic deficit that remained was minimal left arm pronation.A repeat head ct performed 4 weeks later demonstrated cyst recurrence.The patient was readmitted for stereotactic needle aspiration of the cyst followed by intracavitary phosphorus-32 (32p) radioisotope implantation.Prior to 32p implantation, contrast was injected into the cyst.The surgery proceeded without complication and the patient was discharged home with no new neurological deficits.Follow-up imaging at 2 months demonstrated no further cyst enlargement and the patient continues to exhibit minimal left-sided weakness.In review of the case, the site noted that while there was no evidence of a cyst on the head ct scan performed 6 months earlier, in comparing scans performed over 3 years, there was evidence of hypodensity within the basal ganglia as early as 5 months after his initial endovascular treatment.The radiologic pattern was most consistent with edema that became more prominent over time.We believe it is likely that the cyst arose secondary to an inflammatory process associated with the stent and coil mass.Also, given the use of a neck remodeling device and the slow radiographic progression, we can also suggest that the cyst resulted from hypoperfusion of the adjacent brain parenchyma due to altered autoregulation in the small vessels covered by the stent.This could lead to encephalomalacic changes, breakdown of the blood¿brain barrier and delayed cyst formation with a high protein content.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AXIUM
Type of Device
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key15916604
MDR Text Key304818406
Report Number2029214-2022-02055
Device Sequence Number1
Product Code HCG
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 12/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/05/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK-NV-AXIUM
Device Catalogue NumberUNK-NV-AXIUM
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/23/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Disability; Hospitalization; Required Intervention;
Patient Age51 YR
Patient SexMale
-
-